Shanooja Shanavas

Luminescent 11-{Naphthalen-1-yl}dipyrido[3,2-a:2′,3′-c]phenazine-Based Ru(II)/Ir(III)/Re(I) Complexes for HCT-116 Colorectal Cancer Stem Cell Therapy

Utpal Das, Shanooja Shanavas, Apoorva H. Nagendra et al. · ACS Applied Bio Materials · 2023 · 19 citations

G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2′-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells

Nilmadhab Roy, Shanooja Shanavas, Binoy Kar et al. · ACS Omega · 2023 · 19 citations · Full text

2-Aryl-1<i>H</i>-imidazo[4,5-<i>f</i>][1,10]phenanthroline-Based Binuclear Ru(II)/Ir(III)/Re(I) Complexes as Mitochondria Targeting Cancer Stem Cell Therapeutic Agents

Binoy Kar, Shanooja Shanavas, Arun Karmakar et al. · Journal of Medicinal Chemistry · 2024 · 17 citations

Mitochondria-targeted half-sandwich iridium(<scp>iii</scp>)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468

Ashaparna Mondal, Shanooja Shanavas, Utsav Sen et al. · RSC Advances · 2022 · 15 citations · Full text

Mitigation of chronic glucotoxicity-mediated skeletal muscle atrophy by arachidonic acid

Akash Mitra, Shanooja Shanavas, Debajit Chaudhury et al. · Life Sciences · 2023 · 12 citations